OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models
Vilma Petrikaitė, Nicola d’Avanzo, Christian Celia, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100956-100956
Closed Access | Times Cited: 12

Showing 12 citing articles:

Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma
Yufei Lan, Xiaodie Li, Boyang Liu, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101122-101122
Open Access | Times Cited: 9

The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications
Zhonghao Mao, Bingyu Wang, Teng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 18

Rational design of peptides to overcome drug resistance by metabolic regulation
Min Sun, Le He, Ran Chen, et al.
Drug Resistance Updates (2025), pp. 101208-101208
Closed Access

Bioactivity evaluation of Polygonum minus and identification of synergistic phytochemicals with 5-fluorouracil for colon cancer treatment
Zhongming Yang, Zhongguo Yang, Md Zuki Abu Bakar, et al.
Microchemical Journal (2025) Vol. 210, pp. 112917-112917
Closed Access

Artificial intelligence in tumor drug resistance: Mechanisms and treatment prospects
Jianyou Gu, Junfeng Zhang, Silüe Zeng, et al.
(2025)
Closed Access

Ultra-efficient radio-immunotherapy for reprogramming the hypoxic and immunosuppressive tumor microenvironment with durable innate immune memory
Jichun Yang, Chong Zhang, Xiaohong Chen, et al.
Biomaterials (2023) Vol. 302, pp. 122303-122303
Closed Access | Times Cited: 10

Anti-tumor therapy of glycyrrhetinic acid targeted liposome co-delivery of doxorubicin and berberine for hepatocellular carcinoma
Na Xu, Jingliang Wu, Weihao Wang, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 9, pp. 2386-2402
Closed Access | Times Cited: 3

Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer
Zhijie Xu, Zhiyang Zhou, Xiaoxin Yang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3

C-end rule peptide-guided niosomes for prostate cancer cell targeting
Nicola d’Avanzo, Valeria Sidorenko, Lorena Simón‐Gracia, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105162-105162
Open Access | Times Cited: 5

67th International Open Readings Conference for students of Physics and Natural Sciences. Annual Abstract Book 2024
Martynas Keršys, Rimantas Naina, V. A. Adomaitis, et al.
Vilnius University Proceedings (2024) Vol. 46, pp. 1-410
Open Access | Times Cited: 1

Hollow MIL-125 Nanoparticles Loading Doxorubicin Prodrug and 3-Methyladenine for Reversal of Tumor Multidrug Resistance
Qingfeng Guo, Jie Li, Jing Mao, et al.
Journal of Functional Biomaterials (2023) Vol. 14, Iss. 11, pp. 546-546
Open Access | Times Cited: 3

Synthesis and effect of 4-acetylphenylamine-based imidazole derivatives on migration and growth of 3D cultures of breast, prostate and brain cancer cells
Božena Golcienė, Rita Vaickelionienė, Ugnė Endriulaitytė, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Page 1

Scroll to top